about
The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portionsDiscovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell modelsMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentTumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptorsExpression and function of NKRP1A molecule on human monocytes and dendritic cellsIL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activationp40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factorExpression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activityImatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemiaCatastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survivalHuman gammadelta T cells: a nonredundant system in the immune-surveillance against cancer.Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activitySelective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cellsPECAM-1, apoptosis and CD34+ precursors.Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment.Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells.Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2DInhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarctionMechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases.Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.Accelerated repair and reduced mutagenicity of DNA damage induced by cigarette smoke in human bronchial cells transfected with E.coli formamidopyrimidine DNA glycosylase.NK cell autoreactivity and autoimmune diseases.Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation.Stress immunity in lymphomas: mesenchymal cells as a target of therapy.Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells.Effects on Energy Metabolism of Two Guanidine Molecules, (Boc)2 -Creatine and Metformin.The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.Combined platelet and plasma derivatives enhance proliferation of stem/progenitor cells maintaining their differentiation potential.Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity.The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.
P50
Q24310543-2D07343A-ABC9-4167-B70D-2D3E46DFDFF4Q27704009-F62C816D-3EE2-4849-8785-722ACCA7EF7EQ28073613-87E2F6EF-83AB-45CB-A821-DFD8F7E3322FQ28236575-3CE90D28-6ED7-43DD-9AA6-E950C8127C4CQ28256187-5836A2B8-D40F-4A6E-B5EC-15ABF7C2A30EQ28271984-959CD800-39AE-43B9-BFE2-FDACE20B9598Q28278491-5CE2488B-4018-4A91-A8BF-EAFDC1CA5266Q28280383-5D3C968D-BEC0-41FA-9652-B11A98F5C412Q28477798-4008694D-EF95-41BC-B9F4-6D22F9B88FA7Q30912415-A08D6882-A7E8-4FC2-9F78-2A990DAC5DB8Q34166502-E75D71F9-322A-4748-87E1-21A920F6B856Q34451498-353A6A03-2924-4F7C-8373-83FFA71D7072Q34500914-DCF8CCF6-188A-4E55-8627-AD6AE35963AAQ34528331-B8CCD6B1-80BE-41C1-A871-A3A85C2AC1E2Q34634272-64F357B0-6A40-4BBC-A8C3-3F86227CB19AQ34717893-424AE616-66D0-41B3-B41B-DE516ABBA6B6Q35932028-0DF31628-E5FC-457B-8FB8-BA01AE47B2D6Q36038492-DBF0E2A2-9B1B-4C08-BDF3-B974221883CCQ36139709-5860A834-FB84-4E8C-9AAB-31B3A83B519DQ36281238-A855CB38-E0A2-4750-9CB6-27C1A0AC8F11Q36502302-41F4E2AC-2B2B-406F-8164-853843EB9192Q36545914-17BB42D7-5D01-4E6F-A73C-953A801802D1Q36619346-DBF07F6F-9280-43CE-B52F-FDD707A59540Q37066094-65206D50-97CD-42FD-884D-BCDBE69FE264Q37279445-3BED97E6-8139-4FE3-AB55-5F9CEB9F5128Q37427804-9B39E811-F357-4FED-931D-DCDB33A9CF40Q37539349-B637E03C-8174-4576-B9DC-7FD33D92C062Q37552129-C3C11068-A475-4398-B753-D17D05BF3894Q37630626-0FED79B6-D39A-4A58-A735-0FD3A2DFE040Q38175723-5572523B-B91B-45EC-91E7-B3FF68118F5CQ38198424-B95D51FC-6F30-49C0-896E-584214472E1BQ38271585-CD7E546A-2D59-41BB-85E5-C7D89860D105Q38716421-C70DBE21-FC32-432E-8886-5D9FF51B846BQ38719175-543B8971-A7DD-42CC-A987-16B3D9E0FA97Q38816113-6E4AB937-ADAA-4C2C-A51B-7F1BCB97BAEBQ38817994-FC4834BE-AD23-44BC-8138-E0024EA3532CQ38873392-3808D1D1-DA58-4451-9D3B-1E2FA9F65971Q39032882-24BCE30B-0E28-4FD0-BBDF-B252206571A8Q39126650-300AABDE-E16E-4BBC-8111-EA37C2666F18Q39157852-104F4F77-8D2A-4B30-9022-C5291FA4D0A1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alessandro Poggi
@ast
Alessandro Poggi
@en
Alessandro Poggi
@es
Alessandro Poggi
@nl
type
label
Alessandro Poggi
@ast
Alessandro Poggi
@en
Alessandro Poggi
@es
Alessandro Poggi
@nl
prefLabel
Alessandro Poggi
@ast
Alessandro Poggi
@en
Alessandro Poggi
@es
Alessandro Poggi
@nl
P1053
K-6664-2016
P106
P21
P31
P3829
P496
0000-0002-1860-430X